ATE177320T1 - Trimethoprim und ein sulfonamid enthaltende tabletten - Google Patents

Trimethoprim und ein sulfonamid enthaltende tabletten

Info

Publication number
ATE177320T1
ATE177320T1 AT86200589T AT86200589T ATE177320T1 AT E177320 T1 ATE177320 T1 AT E177320T1 AT 86200589 T AT86200589 T AT 86200589T AT 86200589 T AT86200589 T AT 86200589T AT E177320 T1 ATE177320 T1 AT E177320T1
Authority
AT
Austria
Prior art keywords
sulfonamide
tablets containing
containing trimethoprim
trimethoprim
salt
Prior art date
Application number
AT86200589T
Other languages
English (en)
Inventor
Hong Sheng Tan
Bernardus Bartholomeus Wegman
Original Assignee
Yamanouchi Europ Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Europ Bv filed Critical Yamanouchi Europ Bv
Application granted granted Critical
Publication of ATE177320T1 publication Critical patent/ATE177320T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT86200589T 1985-05-02 1986-04-07 Trimethoprim und ein sulfonamid enthaltende tabletten ATE177320T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP85200692A EP0199855A1 (de) 1985-05-02 1985-05-02 Trimethoprim und ein Sulfonamid enthaltende Tabletten

Publications (1)

Publication Number Publication Date
ATE177320T1 true ATE177320T1 (de) 1999-03-15

Family

ID=8194017

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86200589T ATE177320T1 (de) 1985-05-02 1986-04-07 Trimethoprim und ein sulfonamid enthaltende tabletten

Country Status (8)

Country Link
US (2) US4711777A (de)
EP (1) EP0199855A1 (de)
JP (1) JPS6219A (de)
AT (1) ATE177320T1 (de)
DE (1) DE3650716T2 (de)
DK (1) DK197086A (de)
GR (1) GR861148B (de)
PT (1) PT82487B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0199855A1 (de) * 1985-05-02 1986-11-05 Gist-Brocades N.V. Trimethoprim und ein Sulfonamid enthaltende Tabletten
US4894239A (en) * 1987-06-02 1990-01-16 Takeda Chemical Industries, Ltd. Sustained-release preparation and production thereof
US5049394A (en) * 1987-09-11 1991-09-17 E. R. Squibb & Sons, Inc. Pharmaceutical composition containing high drug load and method for preparing same
WO1990001969A1 (en) * 1988-08-24 1990-03-08 Slepian Marvin J Biodegradable polymeric endoluminal sealing
US5634946A (en) * 1988-08-24 1997-06-03 Focal, Inc. Polymeric endoluminal paving process
US5256699A (en) * 1988-10-18 1993-10-26 Ciba-Geify Corporation Dispersible tablet formulation of diclofenac acid free base
CA2002492A1 (en) * 1988-11-11 1990-05-11 Sandra T. A. Malkowska Pharmaceutical ion exchange resin composition
SE9003903D0 (sv) * 1990-12-07 1990-12-07 Astra Ab New pharmaceutical formulations
MY110880A (en) * 1991-01-30 1999-06-30 The Wellcome Foundation Ltd Water-dispersible tablets
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
GB9215908D0 (en) * 1992-07-27 1992-09-09 Wellcome Found Water dispersible tablets
JPH0710747A (ja) * 1993-04-28 1995-01-13 Takeda Chem Ind Ltd 固形製剤およびその製造方法
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
US5853383A (en) * 1995-05-03 1998-12-29 Alza Corporation Preparation for formulations for electrotransport drug delivery
RU2141823C1 (ru) * 1997-04-03 1999-11-27 Открытое акционерное общество "АЙ СИ ЭН Лексредства" Твердая лекарственная форма на основе сульфаметоксазола и триметоприма
EP1429728A1 (de) * 2001-08-29 2004-06-23 SRL Technologies, Inc. Zubereitungen mit verzögerter freisetzung
DE10248652A1 (de) * 2002-10-18 2004-04-29 Solvay Interox Gmbh Verfahren zur Herstellung von staubfreien Erdalkaliperoxiden
RU2237478C2 (ru) * 2002-12-25 2004-10-10 Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" Антимикробная фармацевтическая композиция
CN112190557B (zh) * 2020-09-18 2022-08-09 河北君临药业有限公司 一种复方磺胺甲噁唑片及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3091574A (en) * 1961-09-05 1963-05-28 Bristol Myers Co Tablet disintegrants
US4209513A (en) * 1974-02-14 1980-06-24 Burroughs Wellcome Co. Tablet formulation
GB2067900B (en) * 1980-01-25 1983-06-22 Ddsa Pharmaceuticals Ltd Medicinal tablets
EP0199855A1 (de) * 1985-05-02 1986-11-05 Gist-Brocades N.V. Trimethoprim und ein Sulfonamid enthaltende Tabletten

Also Published As

Publication number Publication date
JPS6219A (ja) 1987-01-06
GR861148B (en) 1986-08-14
US4774083A (en) 1988-09-27
DK197086D0 (da) 1986-04-30
DK197086A (da) 1986-11-03
DE3650716D1 (de) 1999-04-15
EP0199855A1 (de) 1986-11-05
PT82487B (pt) 1989-01-17
DE3650716T2 (de) 1999-07-22
US4711777A (en) 1987-12-08
PT82487A (en) 1986-05-01

Similar Documents

Publication Publication Date Title
ATE177320T1 (de) Trimethoprim und ein sulfonamid enthaltende tabletten
FR2582513B1 (fr) Compositions pharmaceutiques contenant de l'alfuzosine
DE3650721D1 (de) Endmodifizierte Blockcopolymere enthaltende Zusammensetzungen
BE890028A (fr) Poudre a base de sel d'addition d'acide de bacampicilline-micro-encapsule et composition pharmaceutique la contenant
FR2586562B1 (fr) Composition pharmaceutique contenant de l'a-methylhistamine
MX163269B (es) Procedimiento para la polimerizacion en masa de diciclopentadieno
DE3677062D1 (de) Quelle geladener teilchen.
FI873087A0 (fi) Desensiterande dentalkomposition.
MX164826B (es) Composicion de cloruro de vinilideno y pelicula hecha a partir de la misma
KR870700005A (ko) 하나이상의 활성성분을 함유하는 살충제 조성물
IT8521603A0 (it) Composizioni farmaceutiche contenenti come principi attivi flavanolignani e fosfolipidi.
IT1212909B (it) Preparato medicinale per la cura dell'ulcera gastroduodenale
IT7947888A0 (it) Procedimento di preparazione e composizione per la prevenzione ed il trattamento dell'artrite reumatoide e simili
DK284585A (da) 1,4-dihydropyrinderivater, fremgangsmaade til fremstilling af saadanne forbindelser samt laegemiddel indeholdende disse
DK112287A (da) Anvendelse af 2-alkoxy-n-(1-azabicyclo-oe2,2,2aaoct-3-yl)-benzamider og -thiobenzamider samt farmaceutisk acceptable syreadditionssalte deraf som laegemidler
IL88159A0 (en) Salts of pentamidine and pharmaceutical compositions containing the same
IT8520234A0 (it) Composizione farmaceutiche adattivita' dopominergica.
IT8222593A0 (it) Procedimento di preparazione dell'erbicida phenmedipham.
DK92686A (da) Fremgangsmaade til fremstilling af ''levende'' polymerer
SU935711A1 (ru) Электромагнитные весы
IT8520273A0 (it) Composizioni farmaceutiche adattivita' antigalattopoietica.
DK86488D0 (da) Monobasisk phosphatsalt af dobutamin, fremgangsmaade til fremstilling af et saadant salt samt farmaceutisk praeparat indeholdende saltet
DK423385A (da) Laegemiddel samt anvendelse af alfa-interferoner til fremstilling af et middel til behandling af diarre
IT1186709B (it) Artoprotesi dell'anca con verticalizzazione dell'articolazione
IT8620072A0 (it) Sale dell'acido 2',4'-difluoro-4-idrossi-3-bifenilcarbossilico, sua preparazione e composizioni farmaceutiche che lo contengono.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time